Wenhai Sui

1.5k total citations
35 papers, 841 citations indexed

About

Wenhai Sui is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Wenhai Sui has authored 35 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Wenhai Sui's work include Cardiac Fibrosis and Remodeling (6 papers), Signaling Pathways in Disease (6 papers) and Aortic aneurysm repair treatments (4 papers). Wenhai Sui is often cited by papers focused on Cardiac Fibrosis and Remodeling (6 papers), Signaling Pathways in Disease (6 papers) and Aortic aneurysm repair treatments (4 papers). Wenhai Sui collaborates with scholars based in China, Bangladesh and Thailand. Wenhai Sui's co-authors include Yun Zhang, Cheng Zhang, Fei Xue, Cheng Cheng, Meng Zhang, Panpan Hao, Jing Cheng, Wenqiang Chen, Meng Zhang and Zhe-Yu Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Wenhai Sui

33 papers receiving 838 citations

Peers

Wenhai Sui
Wenhai Sui
Citations per year, relative to Wenhai Sui Wenhai Sui (= 1×) peers Qiuhuan Yuan

Countries citing papers authored by Wenhai Sui

Since Specialization
Citations

This map shows the geographic impact of Wenhai Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhai Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhai Sui more than expected).

Fields of papers citing papers by Wenhai Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenhai Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhai Sui. The network helps show where Wenhai Sui may publish in the future.

Co-authorship network of co-authors of Wenhai Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Wenhai Sui. A scholar is included among the top collaborators of Wenhai Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenhai Sui. Wenhai Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jun, Jianlin Zhang, Yifei Li, et al.. (2025). ADAM17 knockdown is more effective than AT1R blocker in alleviating diabetic cardiomyopathy through downregulating the RhoA-ROCK1 pathway. International Immunopharmacology. 162. 115168–115168.
2.
Cao, Lei, Jie Zhang, Wei Yang, et al.. (2025). E3 ubiquitin ligase Listerin regulates macrophage cholesterol efflux and atherosclerosis by targeting ABCA1. Journal of Clinical Investigation. 135(16). 4 indexed citations
3.
Xue, Fei, Cheng Cheng, Wenhai Sui, et al.. (2024). Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis. Signal Transduction and Targeted Therapy. 9(1). 273–273. 16 indexed citations
4.
Zhang, Jianlin, et al.. (2024). Medium‐Dose Formoterol Attenuated Abdominal Aortic Aneurysm Induced by EPO via β2AR/cAMP/SIRT1 Pathway. Advanced Science. 11(15). e2306232–e2306232. 5 indexed citations
5.
Lu, Yue, Xinlu Wang, Wenhai Sui, et al.. (2024). Paraspeckle protein NONO attenuates vascular calcification by inhibiting bone morphogenetic protein 2 transcription. Kidney International. 105(6). 1221–1238. 9 indexed citations
6.
Xie, Lin, Dejin Zang, Jianmin Yang, et al.. (2024). Combination of ADAM17 knockdown with eplerenone is more effective than single therapy in ameliorating diabetic cardiomyopathy. Frontiers in Pharmacology. 15. 1364827–1364827. 4 indexed citations
7.
Zhang, Yujie, Changhao Liu, Xiao Wu, et al.. (2023). Heterogeneity of macrophages in atherosclerosis revealed by single‐cell RNA sequencing. The FASEB Journal. 37(3). e22810–e22810. 23 indexed citations
8.
Sun, Xiaoting, Wenhai Sui, Zepeng Mu, et al.. (2023). Mirabegron displays anticancer effects by globally browning adipose tissues. Nature Communications. 14(1). 7610–7610. 15 indexed citations
9.
Lu, Yue, Xinlu Wang, Cheng Cheng, et al.. (2023). NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways. Science Advances. 9(31). eadd4222–eadd4222. 53 indexed citations
10.
Wang, Jue, et al.. (2023). Circulating Selenium Level Was Positively Related to Visceral Adiposity Index with a Non-linear Trend: a Nationwide Study of the General Population. Biological Trace Element Research. 202(7). 2921–2930. 1 indexed citations
11.
Zhang, Yun, et al.. (2023). Association Between Blood Selenium Levels and Stroke: A Study Based on the NHANES (2011-2018). Biological Trace Element Research. 202(1). 25–33. 8 indexed citations
12.
Yang, Wei, Qiming Deng, Zunzhe Wang, et al.. (2023). NKRF in Cardiac Fibroblasts Protects against Cardiac Remodeling Post‐Myocardial Infarction via Human Antigen R. Advanced Science. 10(30). e2303283–e2303283. 12 indexed citations
13.
Cao, Lei, Amy Gao, Qian Li, et al.. (2023). E3 ligase RNF99 negatively regulates TLR-mediated inflammatory immune response via K48-linked ubiquitination of TAB2. Cell Death and Differentiation. 30(4). 966–978. 13 indexed citations
14.
Cheng, Cheng, Xiaodong Li, Wenhai Sui, et al.. (2023). NPRC deletion mitigated atherosclerosis by inhibiting oxidative stress, inflammation and apoptosis in ApoE knockout mice. Signal Transduction and Targeted Therapy. 8(1). 290–290. 33 indexed citations
15.
Zhang, Meng, et al.. (2022). An animal model of EPO-induced abdominal aortic aneurysm in WT and Apoe−/− mice. STAR Protocols. 4(1). 101929–101929. 3 indexed citations
16.
Meng, Linlin, Yue Lu, Xinlu Wang, et al.. (2022). Statin therapy protects against abdominal aortic aneurysms by inducing the accumulation of regulatory T cells in ApoE−/− mice. Journal of Molecular Medicine. 100(7). 1057–1070. 6 indexed citations
17.
Zhang, Jie, Lei Cao, Xiaohong Wang, et al.. (2021). The E3 ubiquitin ligase TRIM31 plays a critical role in hypertensive nephropathy by promoting proteasomal degradation of MAP3K7 in the TGF-β1 signaling pathway. Cell Death and Differentiation. 29(3). 556–567. 42 indexed citations
18.
Xue, Fei, Jianmin Yang, Jing Cheng, et al.. (2019). Angiotensin‐(1‐7) mitigated angiotensin II‐induced abdominal aortic aneurysms in apolipoprotein E‐knockout mice. British Journal of Pharmacology. 177(8). 1719–1734. 23 indexed citations
19.
Cheng, Jing, Fei Xue, Meng Zhang, et al.. (2018). TRIM31 Deficiency Is Associated with Impaired Glucose Metabolism and Disrupted Gut Microbiota in Mice. Frontiers in Physiology. 9. 24–24. 22 indexed citations
20.
Huang, Shuhong, Jue Wang, Wenhai Sui, et al.. (2013). BDNF-Dependent Recycling Facilitates TrkB Translocation to Postsynaptic Density during LTP via a Rab11-Dependent Pathway. Journal of Neuroscience. 33(21). 9214–9230. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026